Funding for this research was provided by:
Horizon 2020 (GA 875215)
Received: 1 December 2021
Accepted: 23 July 2022
First Online: 17 August 2022
: Ethical committee procedures are being followed in all sites. Inclusion of participants at a site can start after ethical approval by the local review board. The names of the review boards and the approval references are: Athens, Greece: Ethics and Conduct committee—Athens Medical Center; Ε.Σ. 86, 12-04-22; Coimbra, Portugal: Comissão da Administração Regional de Saúde do Centro; 13-2022, 24-03-2022; Cork/Kerry, Ireland: University College Dublin Human Research Ethics Committee (UCD HREC) and Clinical Research Ethics Committee of the Cork Teaching Hospital (CREC); LS-21-69-Darley, 11-08-2021; Rijeka, Croatia: The Ethical Committee—Faculty of Medicine, University of Rijeka; 2170-24-04-3-21-11, 31-08-2021; Rotterdam, The Netherlands: Medische Ethische Commissie (MEC) – Erasmus Medical Center Rotterdam; MEC-2021-0727, 26-11-2021; Treviso, Italy: Comitato Etico per Sperimentazione Clinica delle province di Treviso e Belluno, and; 1159/CE Marca, 03-03-2022; Valencia, Spain: Comisión de Ética en Investigación Experimental de la Universitat de València; no reference, 07-05-2020. Informed consent will be collected electronically or on paper. Participants can stop their participation at any time during the study, without disclosing reasons for withdrawing.
: Not applicable.
: The authors declare that they have no competing interests.